South African Study
Aimed to evaluate thromboprophylaxis in 110 pregnant women with prosthetic heart valves.
Study discontinued after 11 patients had been enrolled because of 2 deaths in 7 patients randomized to enoxaparin group.
A U.S. study of enoxaparin in 61 non-pregnant patients with prosthetic valves reported no prosthetic valve thromboses.